Outset Medical, Inc.
General ticker "OM" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $48.7M (TTM average)
Outset Medical, Inc. does not follow the US Stock Market performance with the rate: -17.2%.
Estimated limits based on current volatility of 2.1%: low 4.33$, high 4.52$
Factors to consider:
- Total employees count: 354 (-26.2%) as of 2024
- Top business risk factors: History of losses, Sustaining gross margins, Market acceptance of tablo, Operational and conduct risks, Manufacturing risks
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [3.05$, 9.10$]
- 2026-12-31 to 2027-12-31 estimated range: [2.37$, 7.02$]
Financial Metrics affecting the OM estimates:
- Positive: with PPE of -0.6 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -85.55 <= 0.07
- Positive: Inventory ratio change, % of -7.03 <= -0.75
- Positive: 42.60 < Shareholder equity ratio, % of 48.00 <= 64.25
Short-term OM quotes
Long-term OM plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $130.38MM | $113.69MM | $119.48MM |
| Operating Expenses | $300.15MM | $227.06MM | $186.19MM |
| Operating Income | $-169.77MM | $-113.38MM | $-66.71MM |
| Non-Operating Income | $-2.50MM | $-14.11MM | $-14.22MM |
| Interest Expense | $12.68MM | $23.87MM | $13.95MM |
| R&D Expense | $57.31MM | $38.40MM | $21.23MM |
| Income(Loss) | $-172.27MM | $-127.48MM | $-80.94MM |
| Taxes | $0.52MM | $0.49MM | $0.72MM |
| Profit(Loss)* | $-172.80MM | $-127.98MM | $-163.31MM |
| Stockholders Equity | $122.89MM | $26.82MM | $126.95MM |
| Inventory | $49.22MM | $59.39MM | $47.61MM |
| Assets | $313.80MM | $275.80MM | $264.50MM |
| Operating Cash Flow | $-131.37MM | $-116.30MM | $-46.33MM |
| Capital expenditure | $3.44MM | $0.91MM | $0.80MM |
| Investing Cash Flow | $83.03MM | $103.94MM | $-97.68MM |
| Financing Cash Flow | $43.65MM | $67.87MM | $55.50MM |
| Earnings Per Share** | $-52.27 | $-36.95 | $-10.74 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.